Decreased Respiratory Secretion Viscosity [PE]: Side Effects & Safety Data for 3 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Decreased Respiratory Secretion Viscosity [PE] includes 3 drugs with a combined 15,891 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
3
Drugs in Class
15,891
Combined Reports
All Decreased Respiratory Secretion Viscosity [PE] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| GUAIFENESIN | Guaifenesin and Pseudoephedrine HCl | 8,042 | 158 | 371 | 2.0% |
| DORNASE ALFA | Pulmozyme | 5,438 | 318 | 2,773 | 5.8% |
| ACETYLCYSTEINE | Acetylcysteine | 2,411 | 421 | 1,199 | 17.5% |
Common Side Effects in Decreased Respiratory Secretion Viscosity [PE] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Drug ineffective | 2,083 | 172 |
| No adverse event | 1,365 | 1 |
| Off label use | 985 | 78 |
| Dyspnoea | 768 | 35 |
| Condition aggravated | 590 | 48 |
| Cystic fibrosis | 565 | 7 |
| Product use in unapproved indication | 534 | 17 |
| Hospitalisation | 524 | 4 |
| Cough | 511 | 3 |
| Pneumonia | 508 | 61 |